Erratum: Resistance to Immune Checkpoint Inhibitor Treatment in Non–Small Cell Lung Cancer Clinical Trials: A Perspective From Lung-MAP Investigators

D Deborah B. Doroshow T Ticiana A. Leal S Saiama N. Waqar H Hossein Borghaei D D. Ross Camidge K Konstantin H. Dragnev M Martin J. Edelman D David R. Gandara D David E. Gerber J Jhanelle E. Gray (Department of Thoracic Oncology H. Lee Moffitt Cancer Center and Research Institute Tampa Florida USA) F Fred R. Hirsch H Hatim Husain D David E. Kozono N Natasha B. Leighl B Bob T. Li T Tianhong Li P Philip C. Mack J Joel W. Neal P Paul K. Paik S Sandip P. Patel J Jonathan W. Riess M Mary W. Redman K Karen L. Reckamp

Article Details

Volume / Issue Vol. 44, Issue 23
Published August 10, 2026
Pages 2258-2258
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (23)

D

Deborah B. Doroshow

T

Ticiana A. Leal

S

Saiama N. Waqar

H

Hossein Borghaei

D

D. Ross Camidge

K

Konstantin H. Dragnev

M

Martin J. Edelman

D

David R. Gandara

D

David E. Gerber

J

Jhanelle E. Gray

Department of Thoracic Oncology H. Lee Moffitt Cancer Center and Research Institute Tampa Florida USA

F

Fred R. Hirsch

H

Hatim Husain

D

David E. Kozono

N

Natasha B. Leighl

B

Bob T. Li

T

Tianhong Li

P

Philip C. Mack

J

Joel W. Neal

P

Paul K. Paik

S

Sandip P. Patel

J

Jonathan W. Riess

M

Mary W. Redman

K

Karen L. Reckamp